Lingnau Lutz 4/A
4/A · NEKTAR THERAPEUTICS · Filed Sep 25, 2020
Insider Transaction Report
Form 4/AAmended
Lingnau Lutz
Director
Transactions
- Award
Common Stock
2020-09-22+9,100→ 35,800 total - Award
Stock Option
2020-09-22+18,200→ 18,200 totalExercise: $19.90Exp: 2028-09-21→ Common Stock (18,200 underlying)
Footnotes (3)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
- [F2]This restricted stock unit award vests in full, one year following September 22, 2020.
- [F3]This stock option vests in equal monthly installments over the one-year period beginning on September 22, 2020.